BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Xanthic Biopharma Limited and Aurquest Resources Inc. Announce Closing of RTO Transaction and New Private Placement

  Pursuant to the terms of the Definitive Agreement, Aurquest acquired all of the issued and outstanding common shares of Xanthic from the Xanthic Shareholders.

  December 18, 2017

   · 

  3 min read
• 

  Drug Development

  Novocure Receives FDA IDE Approval for Its PANOVA 3 Phase III Pivotal Clinical Trial in Advanced Pancreatic Cancer

  NovoCure announced today that it has received a FDA Investigational Device Exemption (IDE) approval to initiate its PANOVA 3 clinical trial.

  December 18, 2017

   · 

  5 min read
• Business

  Lifestyle Delivery Systems Signs an Additional Manufacturing and Volatile Extraction Licensee

  Lifestyle Delivery and LDS announced today that it has signed agreements with a California corporation that holds a Permit and CUP for volatile extraction and manufacturing in Adelanto, California.

  December 18, 2017

   · 

  3 min read
• DarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter

  The regulatory approval ensures that consumers in the Australian market will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8 and iPhone X.

  December 18, 2017

   · 

  4 min read
• Business

  Aytu BioScience Announces Appointment of David Green as CFO

  Mr. Green is a highly accomplished CFO, who brings an extensive array of financial, accounting, and operational experience to Aytu.

  December 18, 2017

   · 

  5 min read
• Pharm Country

  Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000 to Develop a Lysin-based Treatment for Skin Infections Caused by Multi-drug Resistant Acinetobacter baumanii

  ANY invested $100,000 in the company’s seed round.

  December 18, 2017

   · 

  4 min read
• Business

  InVivo Therapeutics Announces Executive Management and Board Changes

  InVivo Therapeutics Corporation today announced that Richard Toselli, M.D., has been appointed Acting Chief Executive Officer of InVivo, replacing Mark D. Perrin, who has resigned as Chief Executive Officer and Chairman of InVivo’s Board of Directors.

  December 18, 2017

   · 

  6 min read
• Policy

  IntelGenx Site Obtains GMP Compliant Rating From Health Canada for Manufacturing and Packaging Activities

  The Company successfully achieved a GMP compliant rating, allowing the site to conduct licensable commercial manufacturing and packaging activities of finished dosage forms.

  December 18, 2017

   · 

  3 min read
• 

  Business

  Regeneron, ISA Pharma Ink Strategic Immuno-Oncology Collaboration

  Regeneron and ISA Pharma today announced a clinical collaboration to advance ISA101 in combination with cemiplimaba, a PD-1 antibody.

  December 18, 2017

   · 

  10 min read
• Business

  Arcus Biosciences Appoints David Beier to Board of Directors

  Mr. Beier brings extensive experience in the biopharmaceutical industry, particularly in areas such as healthcare policy, government affairs, regulatory affairs, pricing, healthcare economics and product commercialization.

  December 18, 2017

   · 

  3 min read